GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » Shiller PE Ratio

BZYR (Burzynski Research Institute) Shiller PE Ratio : (As of Apr. 27, 2025)


View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Burzynski Research Institute Shiller PE Ratio Historical Data

The historical data trend for Burzynski Research Institute's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute Shiller PE Ratio Chart

Burzynski Research Institute Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Burzynski Research Institute Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Burzynski Research Institute's Shiller PE Ratio

For the Biotechnology subindustry, Burzynski Research Institute's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burzynski Research Institute's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Shiller PE Ratio falls into.


;
;

Burzynski Research Institute Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Burzynski Research Institute's E10 for the quarter that ended in Nov. 2024 is calculated as:

For example, Burzynski Research Institute's adjusted earnings per share data for the three months ended in Nov. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=0/133.1099*133.1099
=0.000

Current CPI (Nov. 2024) = 133.1099.

Burzynski Research Institute Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201502 0.000 99.032 0.000
201505 -0.005 100.333 -0.007
201508 -0.004 100.548 -0.005
201511 -0.004 100.135 -0.005
201602 -0.010 100.040 -0.013
201605 -0.003 101.355 -0.004
201608 -0.003 101.617 -0.004
201611 -0.003 101.829 -0.004
201702 0.000 102.779 0.000
201705 -0.004 103.256 -0.005
201708 -0.003 103.587 -0.004
201711 -0.003 104.072 -0.004
201802 0.000 105.052 0.000
201805 -0.003 106.148 -0.004
201808 -0.003 106.383 -0.004
201811 -0.003 106.338 -0.004
201902 -0.003 106.649 -0.004
201905 -0.004 108.048 -0.005
201908 -0.003 108.245 -0.004
201911 -0.004 108.519 -0.005
202002 0.000 109.139 0.000
202005 -0.003 108.175 -0.004
202008 -0.002 109.662 -0.002
202011 -0.002 109.793 -0.002
202102 0.000 110.968 0.000
202105 -0.002 113.576 -0.002
202108 -0.002 115.421 -0.002
202111 -0.002 117.269 -0.002
202202 0.000 119.703 0.000
202205 -0.002 123.323 -0.002
202208 -0.002 124.958 -0.002
202211 -0.002 125.607 -0.002
202302 0.000 126.928 0.000
202305 -0.002 128.314 -0.002
202308 -0.002 129.538 -0.002
202311 0.000 129.548 0.000
202402 0.000 130.930 0.000
202405 -0.003 132.509 -0.003
202408 -0.003 132.816 -0.003
202411 0.000 133.110 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Burzynski Research Institute  (OTCPK:BZYR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Burzynski Research Institute Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Burzynski Research Institute Business Description

Traded in Other Exchanges
N/A
Address
9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Executives
Monika Szopa-paszkowiak director 9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff director 9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski director, 10 percent owner 9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood director 9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski officer: Secretary and Treasurer 9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski director 9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki officer: VP of Clinical Trials 9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll director 9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski director, 10 percent owner, officer: President 9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson officer: Chief Financial Officer 9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute Headlines

No Headlines